This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Daniel Samson, PhD
Vice President, Head Oligonucleotides at Bachem AG
Speaker

Profile

Daniel Samson, Vice President, Head of Oligonucleotides, leads Bachem's oligonucleotide unit including innovation projects, Research & Development, and manufacturing activities. He holds a PhD in organic chemistry from the University of Konstanz, and an Executive MBA from the International Institute for Management Development (IMD), Lausanne. In previous stages of his career, he was a lab head for CMC development, process optimization, technology transfer, quality by design, and scale-up of synthetic peptide manufacturing procedures and Vice President Peptide Manufacturing.


Agenda Sessions

  • Going Large-scale with Manufacturing of Oligonucleotides

    3:30pm